ANTIVIRAL ACTIVITY AND EMBRYONIC TOXICITY OF MOXIDECTIN AGAINST INFLUENZA VIRUS H9
Author(s)
Hameed R1, Tahir M1, Azeem S1, Anjum MS2, Iqbal MZ3, Tanveer MZ1
1University of Veterinary and Animal Sciences, Lahore, Pakistan., Lahore, Pakistan, 2PMAS- Arid Agriculture University, Rawalpindi, Pakistan, Rawalpindi, Pakistan, 3AIMST University,, Bedong, Kedah Darul Aman, Malaysia, Malaysia
Cytotoxic and antiviral potential of Moxidectin against influenza virus H9 was evaluated. The cytotoxicity of moxidectin was evaluated on primary fibroblast cell line through MTT assay. Antiviral activity in vitro and in vivo was tested on 9-days old chick embryo. Cytotoxicity and antiviral activity of Moxidectin is high at first two conc. 200µg/ml and 100µg/ml while safe at lower conc. 50, 25, 12.5 and 6.25µg/ml. It was concluded that concentrations of moxidectin 200 and 100µg/ml were cytotoxic and lower concentrations were safe. Moxidectin showed strong antiviral activity against influenza virus H9 at all concentrations but found to be safer on concentrations like 50, 25, 12.5 and 6.25µg/ml.
Conference/Value in Health Info
2016-09, ISPOR Asia Pacific 2016, Singapore
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PRM47
Topic
Methodological & Statistical Research
Topic Subcategory
Confounding, Selection Bias Correction, Causal Inference
Disease
Infectious Disease (non-vaccine)